ArticleOncotarget2017

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.

Venkata Lokesh Battula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.